10x Genomics to Participate in the UBS Genomics 2.0 and Medtech Innovations Summit
August 06 2020 - 5:00PM
10x Genomics (Nasdaq: TXG) today announced the company will be
participating in the upcoming UBS Genomics 2.0 and Medtech
Innovations Virtual Summit.
10x Genomics’ management is scheduled to participate in a
fireside chat on Wednesday, August 12 at 8:00 a.m. Pacific Time /
11:00 a.m. Eastern Time. Interested parties may access a live and
archived webcast of the presentation on the “Investors” section of
the company website at: investors.10xgenomics.com
About 10x Genomics10x Genomics is a life
science technology company building products to interrogate,
understand and master biology to advance human health. The
company’s integrated solutions include instruments, consumables and
software for analyzing biological systems at a resolution and scale
that matches the complexity of biology. 10x Genomics products have
been adopted by researchers around the world including 97 of the
top 100 global research institutions and 19 of the top 20 global
pharmaceutical companies, and have been cited in over 1,000
research papers on discoveries ranging from oncology to immunology
and neuroscience. The company's patent portfolio comprises more
than 740 issued patents and patent applications.
Disclosure Information10x Genomics uses filings
with the Securities and Exchange Commission, its website
(www.10xgenomics.com), press releases, public conference calls,
public webcasts and its social media accounts as means of
disclosing material nonpublic information and for complying with
its disclosure obligations under Regulation FD.
ContactsInvestorsinvestors@10xgenomics.com
Mediamedia@10xgenomics.com
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Mar 2024 to Apr 2024
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Apr 2023 to Apr 2024